Diwei N. Zheng
Beijing, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.
Journal: Science translational medicine
Published: August 26, 2026
Inorganic nanomaterials empowering bacteria: a new paradigm for biomedical applications.
Journal: Journal of materials chemistry. B
Published: June 16, 2026
A precision therapy paradigm for noise-induced hearing loss: integrating transcriptome-guided drug repurposing with in situ hydrogel delivery.
Journal: Biomaterials science
Published: March 02, 2026
Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 03, 2025
Nanoformulation-based drug delivery systems for the treatment of gastric cancer: recent developments and future prospects.
Journal: Nanoscale horizons
Published: September 03, 2025
Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: June 13, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity.
Journal: Science immunology
Published: March 21, 2025
Fusobacterium nucleatum in Colorectal Cancer: Ally Mechanism and Targeted Therapy Strategies.
Journal: Research (Washington, D.C.)
Published: January 29, 2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53R249S Mutation and is a Potential Therapeutic Target.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 07, 2025
In-situ injectable hydrogel for near-infrared-regulated hyperthermic perfusion therapy of triple-negative breast cancer.
Journal: Journal of colloid and interface science
Published: December 17, 2024
Last Updated: 09/26/2026